Abstract−We determined the minimal fungicidal concentration (MFC) of dihydrosphingosine (DHS), phytosphingosine (PHS) and 5 short-chain DHS derivatives
for Candida albicans and Candida glabrata. We found that a C15-and a C17-homologue of DHS showed a 2-to 10-fold decreased MFC as compared to native DHS (i.e. C18-DHS). DHS derivatives that were active, i.e. comprising 12, 15, 17 or 18 carbon atoms, induced accumulation of reactive oxygen species (ROS) in C. albicans, whereas inactive DHS derivatives, i.e. C5-and C9-DHS, did not. The most active DHS derivatives, i.e.
C15-DHS and C17-DHS, induced ROS production to the highest extent. Interestingly, the presence of 10 mM of the antioxidant ascorbic acid decreased the fungicidal activity of C12-, C15-and C17-DHS against C. albicans, whereas the presence of ascorbic acid had no effect on the fungicidal activity of native DHS and PHS. These data point to a link between the fungicidal activity and ROS induction capacity of selected truncated DHS derivatives in C. albicans.
Long-chain sphingoid bases, e.g. phytosphingosine (PHS), sphingosine and sphinganine (dihydrosphingosine, DHS) inhibit the growth of several yeast and fungal species in vitro, Brevibacterium epidermidis. 5 Cheng and coworkers found that the antifungal activity of DHS and PHS against A. nidulans acts through the rapid induction of metacaspaseindependent apoptosis, associated with the rapid accumulation of reactive oxygen species (ROS). 2 Regarding the in vivo antifungal activity of sphingoid bases, Bibel and coworkers demonstrated that DHS and sphingosine, when topically applied on human skin, are effective against C. albicans infections and also prove curative in experimental guinea-pig models for C. albicans and T. mentagrophytes infections. 6 Interestingly, no gross toxicity was observed among animals or human volunteers 6 , which points to the therapeutic potential of sphingoid bases against fungal infections.
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The aim of this study was to analyse the in vitro antifungal activity of PHS, DHS and truncated analogues of DHS. It has been previously demonstrated that the minimum chain length required for antifungal activity of sphingoid bases against C. glabrata lies in the C7-C18 range, based on the fact that 3 DHS analogues with C6 chain displayed no antifungal activity up to 100 µg/ml. 7 Therefore, we synthesized a series of truncated DHS analogues with C5 (C5-DHS), C9 (C9-DHS), C12 (C12-DHS) or C15 (C15-DHS) chain lengths and determined the minimal fungicidal concentration (MFC) of these derivatives along with C17-DHS, C18-DHS and C18-PHS against Candida albicans strain CAI4 8 and Candida glabrata strain BG2 9 . C. glabrata is a human pathogen with recognized clinical importance due to its association with fungemia caused by fluconazole-resistant yeasts.
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Furthermore, we determined whether C18-PHS, C18-DHS and the DHS derivatives induce ROS accumulation in C. albicans.
C5-DHS: n = 1

C9-DHS: n = 5
C12-DHS: n = 8
C15-DHS: n = 11
C17-DHS: n = 13
C18-DHS: n = 14
C18-PHS Chart 1. Overview of tested compounds
Compounds tested in this study (Chart 1) were obtained as follows. C17-DHS, C18-PHS and C18-DHS were purchased from Avanti Polar Lipids (Alabaster, AL, US). C12-DHS was synthesized as previously described. 11 Compounds C5-DHS, C9-DHS and C15- THF. 13 Selective deprotection of the isopropylidene moiety 13 afforded synthons 2a-c.
Reduction of the alkyne functionality using Pd/C and subsequent deprotection of the tertBoc protecting group under acidic conditions gave access to the envisioned compounds in good overall yield.
Scheme 1. Synthesis of compounds C5-DHS, C9-DHS and C15-DHS.
The fungicidal activity of each compound against C. albicans and C. glabrata was determined in PBS 19 and the MFC for each compound was calculated as the minimal concentration resulting in less than 1% survival of the yeast strain relative to the DMSO control (table 1) . 
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In conclusion, the optimal chain length for fungicidal activity of DHS derivatives against C. albicans and C. glabrata lies between C15 and C17.
In the literature, only two other studies report on derivatives of sphingoid bases with increased antifungal activity. One study describes a series of new PHS analogues with natural or altered stereochemistry at C3 and/or C4, and OH, NH 2 or N 3 substituents at C1, but without alteration of the sphingoid backbone length. 21 The 1-azido derivative, exhibiting the natural D-ribo stereochemistry, showed 10-fold improved antifungal activity against C. albicans as compared to PHS, based on determination of their minimal inhibitory concentration (MIC). However, antifungal activity of the compounds against C. glabrata was not reported. 21 Another study reports on the antifungal activity of dimeric aminoalcohols. 7 The most potent derivative was the dimeric aminoalcohol oceanin, which is characterized by 10-fold improved antifungal activity against C.
glabrata as compared to DHS, based on their MIC. Oceanin is a C28 lipid chain with two polar head groups: one with a (2S,3R)-D-erythro-2-amino-1,3-diol moiety as in natural sphingosine, the other one with a (2R,3R)-2-aminopropan-3-ol group (threo). 7 The MFC of oceanin against C. glabrata is 10 µg/ml. Interestingly, oceanin is not active against C.
albicans.
It should be noted that determination of MFC values is preferred over MIC values, since the former reflects fungicidal activity whereas the latter may account for both fungistatic as well as fungicidal activity. Since fungicidal activity pinpoints to inhibition of targets that are essential for fungal growth 22 or induction of an active cell death pathway (i.e. apoptosis), these values are more relevant for the design of antifungal drugs.
Interestingly, it has previously been demonstrated that PHS and DHS induce apoptosis in
Aspergillus nidulans, concomitant with an accumulation of reactive oxygen species (ROS). 2 In search of the mode of action of PHS, DHS and its derivatives against C. albicans, we determined ROS accumulation upon incubation with various concentrations of the compounds using 2',7'-dichlorofluorescin diacetate staining as previously described. 23 As can be seen in Figure 1 , the inactive C5-DHS and C9-DHS fail to induce ROS, even at 100 µg/ml, whereas C12-, C15-and C17-DHS, and native DHS and PHS induce ROS 7 accumulation in C. albicans. The most active DHS derivatives, i.e. C15-DHS and C17-DHS, induced ROS production to the highest extent. Interestingly, the presence of 10 mM of the antioxidant ascorbic acid decreased the fungicidal activity of C12-, C15-and C17-DHS, whereas the presence of ascorbic acid had no effect on the fungicidal activity of native DHS and PHS (Table 1) . These data point to a link between the fungicidal activity and ROS induction capacity of short-chain DHS derivatives for C. albicans. In contrast, based on our data, there exists no causal link between ROS induction and cell death in yeast in case of native sphingoid bases. In this respect, Cheng and coworkers demonstrated that PHS and DHS induce an ROS-independent apoptotic cell death in Aspergillus nidulans. 2 Hence, our findings point to a ROS-dependent fungicidal activity of short-chain DHS derivatives on yeast, in contrast to the ROS-independent fungicidal activity of native sphingoid bases on yeast. 
